Alopecia areata care for children, teens, and adults · Chaska, Minnesota
Alopecia Areata Diagnosis and Treatment
Sudden smooth patches of hair loss can represent alopecia areata, an autoimmune form of non-scarring hair loss with a wide range of severity. Treatment depends on age, extent, sites involved, disease activity, prior course, and individual goals.
You do not need a confirmed diagnosis before scheduling. Scenic Dermatology evaluates new bald patches, recurrent or more extensive loss, eyebrow or eyelash involvement, and previously diagnosed alopecia areata in children, teenagers, and adults.
What the visit can clarify
A small patch and extensive hair loss call for different conversations.
- Does the pattern fit alopecia areata or another cause?
- How much hair is involved, and is the disease active?
- Would observation, local treatment, or a broader treatment discussion make sense?
- What can regrowth, monitoring, and recurrence realistically look like?
The pattern is a clue, not a self-diagnosis
Is This Alopecia Areata?
Alopecia areata often begins as one or more smooth, round or oval areas of hair loss. The skin usually has little surface change, although alopecia areata can appear in other patterns.
Smooth, discrete patch
A suddenly noticed patch with a smooth surface can fit alopecia areata. Short tapered “exclamation-mark” hairs near an active edge or fine early regrowth may provide additional clues during an examination.
Gradual thinning or recession
A widening part, crown thinning, or slowly receding hairline more often follows a pattern-hair-loss pathway. Scenic’s broader Hair Loss page explains how thinning, shedding, breakage, and patches are evaluated.
Red, scaly, painful, or broken-hair patch
Prominent redness, scale, pain, burning, pustules, broken hairs, or loss of follicular openings can suggest a different inflammatory, infectious, scarring, or hair-shaft process that needs its own diagnosis.
Alopecia areata can involve the scalp, eyebrows, eyelashes, beard, or other body hair. Nails are sometimes affected as well; small pits, roughness, or other texture changes can occur, but most people do not have every feature.
Not every bald patch is alopecia areata. In children, a fungal scalp infection can also cause patchy hair loss and requires very different treatment. Hair pulling can create irregular areas of loss, and inflammatory or scarring disorders have different priorities. An examination helps distinguish these possibilities respectfully and accurately.
Autoimmune and non-scarring
What Alopecia Areata Actually Is
Alopecia areata is an autoimmune condition. Immune activity disrupts the normal hair-growth cycle, but the follicles generally remain structurally present. That is why regrowth can be possible and why ordinary alopecia areata is described as non-scarring hair loss.
The course varies widely. Some people develop one small patch; others have repeated patches, loss around the scalp margins, diffuse loss, eyebrow or eyelash involvement, or much more extensive disease. Alopecia totalis means complete or near-complete scalp hair loss. Alopecia universalis describes very extensive loss involving scalp and body hair. Having a patch does not mean that progression to these forms is inevitable.
Alopecia areata can coexist with atopic dermatitis, thyroid disease, vitiligo, or other immune-related conditions, but one patch does not imply a person has a broad systemic autoimmune illness. History and symptoms determine which associations deserve attention.
Confirm the diagnosis and understand the extent
How a Dermatologist Evaluates Alopecia Areata
Alopecia areata is often diagnosed from the history and examination. The evaluation also asks how active and extensive the disease is, because those findings shape the treatment conversation.
- Clarify the timelineReview when the first area appeared, whether new patches are forming, previous episodes, family and medical history, and prior treatment response.
- Examine the patternAssess the scalp, hair shafts, follicular openings, patch edges, signs of regrowth or activity, and any redness, scale, or scarring clues.
- Check other relevant sitesLook at eyebrows, eyelashes, beard, nails, and other hair-bearing areas when they could change the assessment.
- Estimate extent and burdenConsider total scalp involvement together with sites, progression, symptoms, age, treatment burden, and the effect on school, work, or daily life.
- Test only when usefulUse targeted laboratory testing or biopsy when a specific question could change the diagnosis, safety review, or plan.
- Choose a proportionate next stepDiscuss observation, local treatment, broader therapy, support options, and follow-up based on the whole picture.
Observation can be appropriate; treatment can be appropriate
Does Everyone With Alopecia Areata Need Treatment?
No. A person with one small stable patch may have a very different discussion from someone developing multiple new patches, eyebrow or eyelash loss, or extensive active disease.
An individualized alopecia areata plan brings six questions together:
Age
Comfort, practical burden, and approved treatment options differ for a young child, teenager, and adult.
Extent
One limited area and substantial scalp involvement have different benefit, risk, and treatment-burden tradeoffs.
Sites
Scalp, brows, lashes, beard, and body-hair involvement may respond differently and affect daily life in different ways.
Activity
New or enlarging patches, edge findings, shedding, and the speed of change help show whether disease is active.
Prior course
Duration, earlier regrowth or recurrence, and what previous treatments did can change expectations and next steps.
Patient goals
Visible loss, uncertainty, treatment risks, convenience, and personal preference deserve a direct discussion without assuming everyone wants treatment.
Age + extent + sites + activity + prior course + patient goals lead to an individualized treatment decision. This is a conversation framework, not a self-treatment algorithm.
Observation may be reasonable for selected limited disease because spontaneous regrowth can occur. Treatment may also be reasonable when an area is active, persistent, recurrent, more extensive, involving eyebrows or eyelashes, or important to the patient. Waiting should be a deliberate choice with appropriate follow-up, not a promise that every patch will regrow on its own.
Local options for a local amount of disease
Treatment for Limited Patchy Alopecia Areata
For one or several limited patches, the discussion may focus on observation or treatment directed at the affected areas. No local option guarantees complete or permanent regrowth, and candidacy depends on age, site, activity, comfort, and the examination.
Eyebrows and eyelashes need site-specific judgment. A therapy appropriate for the scalp may not be appropriate near the eyes. Discuss those areas directly rather than transferring a scalp regimen on your own.
Broader disease may justify a broader treatment discussion
Treatment for Extensive or Severe Alopecia Areata
When alopecia areata affects a large part of the scalp, multiple sites, or is progressing substantially, treating individual spots may not match the amount of disease. Systemic treatment can become more relevant.
| Clinical picture | What may become relevant | Why individualization still matters |
|---|---|---|
| One or a few limited patches | Observation, topical therapy, or injections directed at affected areas | Age, activity, site, comfort, prior course, and preference determine whether treatment is worthwhile. |
| Multiple or extensive scalp areas | A broader treatment discussion, including systemic options for appropriate severe disease | Potential benefit must be weighed against screening, monitoring, side effects, access, and recurrence. |
| Eyebrows, eyelashes, or several body sites | Site-specific treatment and a fuller assessment of disease burden | Scalp percentage alone may understate practical or psychosocial impact. |
Where JAK inhibitors fit
Janus kinase (JAK) inhibitors target immune signaling involved in alopecia areata. They have changed the treatment landscape for appropriate patients with severe disease, but they are not interchangeable and are not the right starting point for every person with a bald patch.
As of August 2026, FDA-approved oral options for severe alopecia areata include baricitinib (Olumiant) and deuruxolitinib (Leqselvi) for adults, and ritlecitinib (Litfulo) for adults and adolescents 12 years and older. Baricitinib and deuruxolitinib do not have an FDA-approved alopecia areata indication for children or adolescents.
These medicines have important safety warnings and require individualized review. Depending on the agent and patient, that can include infection and vaccination history, tuberculosis or hepatitis screening, blood counts, liver tests, cholesterol-related testing, pregnancy considerations, medication interactions, and ongoing monitoring. FDA approval does not mean a medicine is appropriate or covered for every patient.
A medication list is not a treatment recommendation. Disease severity, age, health history, pregnancy potential, infection and cardiovascular risk, other medicines, prior course, monitoring, and patient priorities all belong in the decision. Other systemic or specialty treatments may be considered in selected situations, sometimes off-label, without making them routine for everyone.
Insurance and access
Systemic treatment can involve plan-specific requirements
Coverage can depend on diagnosis, severity documentation, age, formulary rules, prior treatments, and authorization requirements. Authorization does not guarantee payment, and Scenic cannot guarantee that a particular medicine will be covered. Review Scenic’s insurance information and verify benefits with your plan.
Age-specific diagnosis and treatment
Alopecia Areata in Children and Teens
Children commonly develop alopecia areata. A sudden smooth patch may be the first sign, but not every patch in a child is autoimmune hair loss, so the scalp should be examined before treatment is chosen.
The evaluation looks for the same core clues as an adult visit while accounting for a child’s age, comfort, other scalp findings, health history, and family priorities. Scale and broken hairs may raise concern for tinea capitis, a fungal infection that follows a different treatment pathway. Irregular broken hairs can have other explanations as well.
For limited disease, observation or topical corticosteroid therapy may be reasonable. Local injections are used selectively because discomfort, number of areas, age, and the child’s preferences matter. Families should hear both sides of the natural history: spontaneous regrowth is possible, and recurrence or new patches can still occur.
Age thresholds become especially important when systemic treatment is discussed. Among the three currently FDA-approved oral JAK inhibitors for severe alopecia areata, only ritlecitinib includes adolescents 12 years and older; baricitinib and deuruxolitinib are approved for adults. An approved age range is only the beginning of the safety and appropriateness review.
Visible hair loss can affect school, activities, unwanted questions, and self-image. The child or teenager should have a voice in how much treatment burden feels acceptable. Wigs, hairpieces, hats, eyebrow cosmetics, or other appearance supports can be useful alongside treatment, while waiting for a response, or without medical treatment. They are not signs of giving up.
Learn more about Scenic’s Pediatric Dermatology care. Parents do not need to determine whether a patch is alopecia areata, fungal hair loss, pulling, or another process before requesting a visit.
Hair biology and autoimmune activity both take time
What to Expect From Treatment and Follow-Up
Visible regrowth usually takes time and varies by severity, duration, site, treatment, and continued disease activity. A response cannot be judged after a few days, and no treatment can promise complete, permanent coverage.
- Define the starting pictureDocument the distribution, extent, active areas, eyebrow or eyelash involvement, nail findings, symptoms, and goals.
- Allow a meaningful intervalUse the agreed plan consistently while reporting important side effects, rapid progression, or new sites.
- Look for more than one kind of progressAssess new regrowth, increased coverage, fewer new areas, reduced disease activity, and eyebrow or eyelash improvement when involved.
- Reassess benefit and burdenReview response, safety, convenience, monitoring, cost or coverage, and whether the working plan still matches the patient’s priorities.
- Plan for recurrenceDecide what to watch, when to return, and how the approach would change if hair loss becomes active again.
Camouflage and support options can improve daily life while medical treatment is being considered or while regrowth develops. They can also be a person’s preferred long-term choice. Medical treatment is not mandatory simply because hair loss is visible.
Diet, vitamins, and supplements
Alopecia areata is not generally cured through an “autoimmune diet,” detox, biotin, or a supplement stack. Nutritional deficiency should be treated when it is actually identified, but routine supplementation does not switch off the autoimmune process. High-dose biotin can also interfere with important laboratory tests.
Useful to bring
Help the visit begin with what you already know
- An approximate start date and whether patches are new, enlarging, or recurring
- Earlier photographs, if available, that show the areas before or during change
- A current medication and supplement list
- Prior alopecia treatments and what happened with each
- Relevant medical or family history and the questions that matter most to you or your child
Dermatologist-led hair loss care in Chaska
Treatment Starts With the Pattern, Extent, and Person
Scenic Dermatology is an independent Chaska practice led by William Miller, MD, MSc, MPH, FAAD, a board-certified dermatologist. Scenic provides diagnosis-first evaluation and individualized medical dermatology care for children, teenagers, and adults.
Review the physician and visit process
Learn about Dr. William Miller’s training and credentials, Scenic’s Medical Dermatology services, and what new patients can expect.
Answers to common questions
Alopecia Areata Frequently Asked Questions
What causes alopecia areata?
Alopecia areata is an autoimmune condition in which immune activity disrupts normal hair growth. Genes and environmental factors may influence susceptibility, but many people cannot identify one specific trigger. It is not caused by poor hair care.
Is alopecia areata permanent?
Not necessarily. The follicles usually remain present, so spontaneous or treatment-associated regrowth can occur. The course is unpredictable, however, and some people have persistent, recurrent, or more extensive disease. Regrowth does not eliminate the possibility of recurrence.
Is alopecia areata contagious?
No. Alopecia areata is an autoimmune condition and cannot be passed from one person to another. Some infectious scalp conditions can also cause patchy hair loss, which is one reason an accurate diagnosis matters.
Does stress cause alopecia areata?
Stress may be one possible trigger or modifier in a susceptible person, but alopecia areata is an autoimmune disease and often appears without an obvious trigger. It is not accurate or helpful to blame a person for failing to control stress.
Can alopecia areata affect eyebrows, eyelashes, or nails?
Yes. It can involve eyebrows, eyelashes, beard, and other body hair, and some people develop nail pitting, roughness, or other changes. These features are not present in everyone, but they can affect assessment, treatment choices, and the practical burden of disease.
Do I need blood tests for alopecia areata?
Many people do not need a broad laboratory panel. Testing is most useful when the history, symptoms, examination, an associated condition, or a treatment being considered raises a specific question. Medication safety testing follows the needs of the particular therapy.
Do I need a scalp biopsy?
Usually not. Alopecia areata can often be diagnosed clinically. Biopsy may help when the pattern is atypical, the diagnosis remains uncertain, or another inflammatory or scarring form of hair loss is being considered.
Do steroid injections work for alopecia areata?
Intralesional corticosteroid injections can promote regrowth in some appropriate patients with limited patchy disease. They may need to be repeated, can be uncomfortable, and can cause local skin effects. They do not guarantee permanent regrowth and are not suitable for every age, site, or extent of disease.
What are JAK inhibitors for alopecia areata?
JAK inhibitors are systemic medicines that target immune-signaling pathways involved in alopecia areata. FDA-approved oral options are available for appropriate severe disease, with agent-specific age indications and important safety warnings, screening, interactions, and monitoring. They are not cures and are not automatically appropriate for every patient.
Can children and teenagers develop alopecia areata?
Yes. Alopecia areata can begin in childhood or adolescence. Diagnosis should distinguish it from fungal scalp infection, hair pulling, breakage, and other causes. Treatment is individualized for age, extent, comfort, course, and family priorities. Only one currently FDA-approved oral JAK option includes adolescents beginning at age 12; the other two are adult-only.
Can diet, vitamins, or biotin cure alopecia areata?
No diet or supplement has been shown to cure the autoimmune process. A documented nutritional deficiency should be treated, but routine biotin, restrictive diets, or “detox” plans can add cost or risk without addressing alopecia areata. High-dose biotin can interfere with some laboratory tests.
When should I see a dermatologist for a bald patch?
An evaluation is useful when a patch is new, enlarging, recurring, uncertain, affecting eyebrows or eyelashes, or accompanied by redness, scale, pain, burning, pustules, or broken hairs. You do not need to know whether it is alopecia areata before scheduling.
Related care
Continue With the Question That Fits
Move from an unexpected patch to a useful next step
Request an Alopecia Areata Evaluation
Scenic Dermatology can examine the pattern, confirm whether it fits alopecia areata, assess extent and activity, and discuss observation or treatment based on age, sites, prior course, safety, and goals.